About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Is There Any Role of Immunotherapy in NSCLC Stage 1 & Stage 2?
By
13th Annual Fall Midwest Thoracic and GI Oncology Conference
FEATURING
Alissa S. Marr
By
13th Annual Fall Midwest Thoracic and GI Oncology Conference
FEATURING
Alissa S. Marr
471 views
December 19, 2018
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
18:47
Total Health
Updates in the Management of NSCLC: Systemic Therapy Year in Review
Feat.
W. Iams
11:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical…
Feat.
J. West
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
26:42
Total Health
ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 AS…
Feat.
J. Bauman
17:57
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Expert Discussion on New Treatment Options…
Feat.
D. Carbone,
B. Stiles
07:38
GRACE
How Does PD-L1 Score Affect Treatment Options for NSCLC
Feat.
S. Patel,
T. Leal,
P. Iyengar,
A. Desai,
C. Kim,
J. Rotow
17:29
Wenhua Liang
Novel Early Management of Lung Cancer
01:42
ecancer
ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysi…
Feat.
R. Herbst
13:43
Total Health
NSCLC Highlights - Best of ASCO® 2023 Meeting
Feat.
M. Das
07:29
ESMO 2022 Conference Coverage
ESMO 2022 Updated Results From ADAURA: Osimertinib as Adjuvant Thera…
Feat.
T. John
13:51
Fox Chase Cancer Center
Adjuvant Treatment of NSCLC: ADAURA in Context
Feat.
M. Edelman
36:38
Community Oncology Alliance
Current Advances in NSCLC
Feat.
G. Riely
07:38
OncoAlert
Radical Intent NSCLC: Targeted Therapies Update
Feat.
S. Popat
06:44
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "The Impact of PET-CT Brain MRI for Metasta…
Feat.
W. Liang
11:12
GRACE
ASCO® 2023 Insights: "The ADAURA Trial for NSCLC - Flaws and Re…
Feat.
J. West,
C. Lovly,
A. Addeo
22:31
David Carbone
Expert Discussion on New Treatment Options for Surgically Resectable…
Feat.
B. Stiles
15:01
OncoAlert
Radiation Oncology 2022: Advances in NSCLC
Feat.
H. Willers,
A. Wisdom
17:32
Total Health
ADAURA Trial Update: Osimertinib in Resected EGFRm NSCLC - Best of L…
Feat.
S. Kazmi
06:10
GRACE
Key Points From the ADAURA Trial: Osimertinib in NSCLC
Feat.
J. Reuss
06:09
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
MET Exon 14 Skipping Mutation in NSCLC: An Analysis by Specific Muta…
Feat.
J. Marks
